Company / Operating Margin
Beam Therapeutics Inc. Operating Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-274.6%
FY2025
5-year range
-757.0% / -46.7%
FY2021-FY2025
Trend
+58.0%
vs FY2024
Sector context
#104 of 136
Health Care
What the data says
Beam Therapeutics Inc.'s operating margin of -274.6% is lower than 76% of companies in the Health Care sector (FY2025). Declined from -46.7% to -274.6% over the past 2 years.
Based on SEC 10-K filings.
-274.6% in FY2025 with a 5-year CAGR of +417247.6%.
Declined from -46.7% to -274.6% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +281.0pp
- 5-Year Change
- +417247.6pp
- 10-Year Change
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 136This company -274.6% Sector average -778.9%
▼
+64.8% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 58.0% year-over-year.
- Currently 504.4pp above the Health Care sector average.
- Peak operating margin was recorded in FY2023.
- Lowest operating margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -274.6% | +58.0% |
| FY2024 | -654.3% | -1300.1% |
| FY2023 | -46.7% | +91.6% |
| FY2022 | -555.6% | +26.6% |
| FY2021 | -757.0% | +99.8% |
| FY2020 | -417522.2% | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026